Putnam BioRevolution ETF Rating $29.70 -0.34 (-1.13%) As of 02/21/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatings Putnam BioRevolution ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SYNB Aggregate RatingModerate Buy 2.81Holdings in SYNB have an aggregate rating of Moderate Buy based on 544 analyst ratings issued in the past year covering 32 companies (93.6% of the portfolio).SYNB Aggregate Price Target$29.70High Prediction$29.70Average Prediction$29.70Low Prediction$29.70Holdings in SYNB have an aggregate price target of $29.70 and a range of $29.70 to $29.70 covering 32 companies (93.6% of the portfolio).SYNB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy27 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Putnam BioRevolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 31 SYNB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.48%TMOThermo Fisher Scientific$532.55-1.0%4.7267 of 5 stars2.82$656.86 23.3%22Dividend IncreaseAnalyst RevisionPositive News6.32%BIOBio-Rad Laboratories$279.48-2.2%4.7938 of 5 stars2.60$395.20 41.4%55.83%DHRDanaher$209.86+0.9%4.992 of 5 stars2.71$278.00 32.5%21Dividend IncreaseAnalyst RevisionPositive News5.25%CTVACorteva$62.75-1.7%4.4731 of 5 stars2.67$67.73 7.9%18News CoveragePositive News4.71%ABBVAbbVie$202.03+0.6%4.641 of 5 stars2.88$208.35 3.1%24Dividend AnnouncementAnalyst RevisionPositive News4.54%GOOGLAlphabet$179.66-2.7%4.6037 of 5 stars2.86$210.62 17.2%43Insider TradePositive News4.39%NVZMYNovozymes A/S$56.040.0%2.3181 of 5 stars3.003News Coverage3.87%AZNAstraZeneca$74.20-0.5%2.6875 of 5 stars3.10$89.75 21.0%10Options Volume3.77%NVDANVIDIA$134.35-4.1%4.9839 of 5 stars2.98$168.21 25.2%42Upcoming EarningsAnalyst ForecastPositive News3.75%LLYEli Lilly and Company$874.12+0.1%4.8421 of 5 stars2.85$1,000.28 14.4%20Positive News3.58%ASNDAscendis Pharma A/S$152.43-1.4%3.1709 of 5 stars2.93$200.21 31.3%14Analyst Forecast3.40%DDDuPont de Nemours$81.67-1.4%4.7405 of 5 stars2.83$98.75 20.9%12Dividend IncreaseAnalyst UpgradePositive News3.35%CDNSCadence Design Systems$258.27-4.4%4.9166 of 5 stars2.75$326.92 26.6%12Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume3.03%EXASExact Sciences$49.26-0.5%4.6827 of 5 stars2.95$72.06 46.3%19Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage2.84%ZTSZoetis$160.39+1.9%4.8684 of 5 stars3.08$215.40 34.3%12Positive News2.73%DARDarling Ingredients$39.18-1.0%4.2498 of 5 stars2.89$53.22 35.8%9News CoveragePositive News2.51%AVTRAvantor$17.31-1.1%4.9225 of 5 stars2.75$25.92 49.8%12Short Interest ↓2.49%REGNRegeneron Pharmaceuticals$700.33+0.6%4.7594 of 5 stars2.76$973.13 39.0%25Dividend Announcement2.31%ONONON$48.23-5.8%3.3738 of 5 stars2.83$59.73 23.8%24Positive News2.30%NGVTIngevity$46.11-1.4%2.7489 of 5 stars2.50$54.67 18.6%6Earnings ReportAnalyst UpgradeNews Coverage1.85%TWSTTwist Bioscience$41.31-8.4%4.5944 of 5 stars2.70$54.40 31.7%10Positive News1.69%ARGXargenx$644.48-0.5%2.4952 of 5 stars2.86$658.39 2.2%22News CoveragePositive News1.54%PPGPPG Industries$114.88-2.6%4.7931 of 5 stars2.53$138.15 20.3%15Insider Trade1.52%TECHBio-Techne$64.92-0.9%4.9189 of 5 stars2.50$84.29 29.8%8Analyst DowngradeInsider TradeNews Coverage1.43%VRTXVertex Pharmaceuticals$484.24+0.8%4.0991 of 5 stars2.65$506.70 4.6%26Analyst DowngradeInsider TradeAnalyst RevisionPositive News1.43%BMRNBioMarin Pharmaceutical$68.25-0.7%4.9101 of 5 stars2.70$93.81 37.4%23Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.13%ALNYAlnylam Pharmaceuticals$250.59-0.2%4.4399 of 5 stars2.72$299.48 19.5%25Analyst ForecastInsider Trade0.92%BGBunge Global$73.12+2.6%4.9496 of 5 stars2.60$93.00 27.2%5Ex-Dividend0.68%RCKTRocket Pharmaceuticals$10.47-3.7%4.517 of 5 stars2.92$47.27 351.5%120.41%LEGNLegend Biotech$39.70+2.0%2.523 of 5 stars3.00$79.50 100.3%12News Coverage0.36%CRSPCRISPR Therapeutics$47.91-5.0%3.157 of 5 stars2.50$74.40 55.3%22Analyst ForecastInsider TradeOptions VolumeAnalyst Revision This page (NYSEARCA:SYNB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
